Literature DB >> 6196587

High-dose intravenous gammaglobulin for Kawasaki disease.

K Furusho, K Sato, T Soeda, H Matsumoto, T Okabe, T Hirota, S Kawada.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6196587     DOI： 10.1016/s0140-6736(83)91109-1

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  19 in total

1.  A history of immune globulin therapy, from the Harvard crash program to monoclonal antibodies.

Authors:  Melvin Berger
Journal:  Curr Allergy Asthma Rep       Date:  2002-09       Impact factor: 4.806

Review 2.  Clinical applications of intravenous immunoglobulins (IVIg)--beyond immunodeficiencies and neurology.

Authors:  H-P Hartung; L Mouthon; R Ahmed; S Jordan; K B Laupland; S Jolles
Journal:  Clin Exp Immunol       Date:  2009-12       Impact factor: 4.330

Review 3.  Pharmacological therapy for patients with Kawasaki disease.

Authors:  R V Williams; L L Minich; L Y Tani
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

4.  Indications for intravenous gammaglobulin therapy in inflammatory myopathies.

Authors:  P Cherin; S Herson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-11       Impact factor: 10.154

Review 5.  The immunomodulatory effects of intravenous immunoglobulin therapy in Kawasaki disease.

Authors:  Jane C Burns; Alessandra Franco
Journal:  Expert Rev Clin Immunol       Date:  2015       Impact factor: 4.473

6.  Kawasaki disease: a case report every otolaryngologist should know.

Authors:  Saurav Sarkar; Sudip Dawn; Amitabha Roychoudhury; B K Roychaudhuri
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2011-07-09

Review 7.  Indications for IVIG in rheumatic diseases.

Authors:  Ben Mulhearn; Ian N Bruce
Journal:  Rheumatology (Oxford)       Date:  2014-11-17       Impact factor: 7.580

Review 8.  Epidemiology and management of Kawasaki disease.

Authors:  Nadia J C Luca; Rae S M Yeung
Journal:  Drugs       Date:  2012-05-28       Impact factor: 11.431

9.  A Retrospective Cohort Study of Intravenous Immunoglobulin Therapy in the Acute Phase of Kawasaki Disease: The Earlier, the Better?

Authors:  Wei Li; Xiufang He; Li Zhang; Zhouping Wang; Yanfei Wang; Huimei Lin; Jia Yuan; Xiaofei Xie; Youzhen Qin; Ping Huang
Journal:  Cardiovasc Ther       Date:  2021-06-18       Impact factor: 3.023

Review 10.  Intravenous immunoglobulin for the treatment of Kawasaki disease in children.

Authors:  R M Oates-Whitehead; J H Baumer; L Haines; S Love; I K Maconochie; A Gupta; K Roman; J S Dua; I Flynn
Journal:  Cochrane Database Syst Rev       Date:  2003
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.